Telomir Pharmaceuticals reports reversal of oxidative stress
Telomir Pharmaceuticals , Inc. (NASDAQ:TELO), a $141 million market cap biopharmaceutical company engaged in age-reversal science, has announced significant preclinical study results today, indicating ...
Q&A: Bird flu basics from an infectious disease expert
The H5N1 Avian influenza is decimating bird populations around the world. More than 136 million birds have been affected in ...